免疫組織化學市場規模、佔有率和成長分析：按產品、應用、最終用途和地區分類－2026-2033年產業預測

2024 年全球免疫組織化學市場價值為 29 億美元，預計到 2025 年將成長至 31.1 億美元，到 2033 年將成長至 55.1 億美元，在預測期（2026-2033 年）內複合年成長率為 7.4%。

全球免疫組織化學市場正經歷顯著成長，這主要得益於自動化和機器學習技術的日益普及以及先進免疫組織化學解決方案的湧現。複雜的操作流程使得人們越來越依賴免疫組織化學進行精準的疾病診斷，推動了市場需求的激增。隨著醫療專業人員尋求更有效率、更可靠的診斷工具，將創新技術融入免疫組織化學有望提高病理診斷的準確性和效率，並重塑市場格局。這些因素共同反映了醫療保健領域對精準診斷和個人化醫療的日益重視，從而推動了市場的顯著擴張。這一發展勢頭也促使免疫組織化學的應用朝著技術先進的方向發展。

全球免疫組織化學市場成長要素

全球免疫組織化學市場的主要促進因素之一是癌症和心血管疾病等慢性疾病的日益普遍。這些疾病的早期檢測和個人化治療方案需要先進的診斷技術。隨著醫療專業人員越來越依賴免疫組織化學進行精準的組織分析和生物標記鑑定，對先進診斷工具的需求持續成長。此外，病理學和腫瘤學領域研發投入的不斷增加也進一步推動了市場發展，抗體生產和檢測技術的創新提高了診斷的準確性和有效性，最終改善了患者的治療效果，並促進了市場成長。

限制全球免疫組織化學市場的因素

全球免疫組織化學市場的主要限制因素之一是先進技術和設備的高成本。免疫組織化學檢測複雜，需要專用試劑、抗體和設備，這對於小規模檢查室和醫療機構而言，尤其是在發展中地區，可能非常昂貴且難以實施。此外，準確解讀結果需要專業人員，這進一步增加了營運成本。這種經濟負擔可能會限制某些醫療機構採用免疫組織化學技術，可能會限制市場成長。此外，醫療系統的預算限制可能導致人們傾向於選擇成本較低的診斷方法，這可能會降低對這些先進診斷解決方案的需求。

全球免疫組織化學市場趨勢

全球免疫組織化學 (IHC) 市場正經歷著一場由人工智慧 (AI) 和數位病理學融合驅動的重大變革。這項技術進步正在加速影像分析工作流程的自動化，並提高診斷過程的可靠性和可重複性。人工智慧平台能夠更精確地量化和識別細微的形態學特徵，同時也有助於遠距組織學評估。這種向數據驅動型診斷的轉變不僅最佳化了數據管理，還促進了醫療機構之間的合作。隨著人工智慧輔助調查方法在臨床實踐中日益普及，它們正在重塑診斷病理學的格局，發揮著至關重要的作用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 一手數據和二手數據的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 行業概覽
• 競爭環境概述

市場動態與展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

主要市場因素

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球免疫組織化學市場規模：依產品類別分類

• 抗體
• 裝置
• 試劑
• 成套工具

全球免疫組織化學市場規模：按應用領域分類

• 診斷
• 癌症
• 感染疾病
• 心血管疾病
• 自體免疫疾病
• 糖尿病
• 腎臟疾病

全球免疫組織化學市場規模：依最終用途分類

• 醫院和實驗室
• 研究機構

全球免疫組織化學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• F. Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Abcam plc
• Merck KGaA
• Cell Signaling Technology, Inc.
• Bio-Techne Corporation
• Sakura Finetek USA, Inc.
• PerkinElmer, Inc.
• Biocare Medical, LLC
• Leica Biosystems
• Canon Medical Systems Corporation
• Dako（安捷倫科技公司的子公司）
• Miltenyi BIoTec
• Sigma-Aldrich（part of Merck KGaA）
• Biogen Idec
• Thermo Scientific
• Wako Pure Chemical Industries, Ltd.

結論與建議

Global Immunohistochemistry Market size was valued at USD 2.9 Billion in 2024 and is poised to grow from USD 3.11 Billion in 2025 to USD 5.51 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global immunohistochemistry market is experiencing significant growth driven by the rising adoption of automation and machine learning technologies, along with the emergence of advanced IHC solutions. Enhanced protocols have led to greater reliance on IHC for accurate disease diagnosis, contributing to its escalating demand. As healthcare providers seek more efficient and reliable diagnostic tools, the integration of innovative technologies in immunohistochemistry is poised to reshape the landscape, offering improved accuracy and efficiency in pathology. The combination of these factors positions the market for considerable expansion, reflecting an increasing focus on precision diagnostics and personalized medicine in the healthcare sector. This momentum underscores a strategic shift towards technologically sophisticated approaches in immunohistochemical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segments Analysis

Global Immunohistochemistry Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Antibodies, Equipment, Reagents and Kits. Based on Application, the market is segmented into Diagnostics, Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases. Based on End Use, the market is segmented into Hospitals & Laboratories and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunohistochemistry Market

One of the key market drivers for the global immunohistochemistry market is the rising prevalence of chronic diseases, such as cancer and cardiovascular disorders, which necessitate advanced diagnostic techniques for early detection and personalized treatment options. As healthcare providers increasingly rely on immunohistochemistry for accurate tissue analysis and biomarker identification, the demand for sophisticated diagnostic tools continues to surge. Additionally, the growing emphasis on research and development in pathology and oncology further propels the market, as innovations in antibody production and assay technologies enhance diagnostic accuracy and efficacy, ultimately improving patient outcomes and driving market growth.

Restraints in the Global Immunohistochemistry Market

One significant market restraint for the global immunohistochemistry market is the high cost associated with advanced techniques and equipment. The intricate nature of immunohistochemistry assays requires specialized reagents, antibodies, and instrumentation, which can be prohibitively expensive for smaller laboratories and healthcare facilities, especially in developing regions. Additionally, the necessity for skilled personnel to accurately interpret results further escalates operational costs. This financial burden may limit the adoption of immunohistochemistry technologies in certain healthcare settings, consequently constraining market growth. Furthermore, budget constraints within healthcare systems could lead to prioritization of less costly diagnostic methods, reducing demand for these advanced diagnostic solutions.

Market Trends of the Global Immunohistochemistry Market

The global immunohistochemistry (IHC) market is witnessing a significant transformation driven by the integration of artificial intelligence and digital pathology. This technological advancement enhances the automation of image analysis workflows, thereby improving the reliability and reproducibility of diagnostic processes. AI-powered platforms are enabling more precise quantification and the identification of subtle morphological traits, while also facilitating remote histological evaluations. This shift towards data-driven diagnostics not only optimizes data management but also fosters collaborative practices among healthcare institutions. As AI-assisted methodologies gain traction in clinical settings, they are becoming pivotal in redefining the landscape of diagnostic pathology.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Immunohistochemistry Market Size by Product & CAGR (2026-2033)

• Market Overview
• Antibodies
• Equipment
• Reagents
• Kits

Global Immunohistochemistry Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Cancer
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Diabetes Mellitus
• Nephrological Diseases

Global Immunohistochemistry Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Laboratories
• Research Institutes

Global Immunohistochemistry Market Size & CAGR (2026-2033)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dako (a subsidiary of Agilent Technologies)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich (part of Merck KGaA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Idec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wako Pure Chemical Industries, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations